Mechanistic role of heat shock protein 70 in Bcr-Abl-mediated resistance to apoptosis in human acute leukemia cells - PubMed (original) (raw)

. 2005 Feb 1;105(3):1246-55.

doi: 10.1182/blood-2004-05-2041. Epub 2004 Sep 23.

Celia Sigua, Purva Bali, Prince George, Warren Fiskus, Anna Scuto, Srinivas Annavarapu, Abdelmoughite Mouttaki, Gautam Sondarva, Sheng Wei, Jie Wu, Julie Djeu, Kapil Bhalla

Affiliations

• PMID: 15388581
• DOI: 10.1182/blood-2004-05-2041

Free article

Mechanistic role of heat shock protein 70 in Bcr-Abl-mediated resistance to apoptosis in human acute leukemia cells

Fei Guo et al. Blood. 2005.

Free article

Abstract

Bcr-Abl-expressing primary or cultured leukemia cells display high levels of the antiapoptotic heat shock protein (hsp) 70 and are resistant to cytarabine (Ara-C), etoposide, or Apo-2L/TRAIL (TNF-related apoptosis-inducing ligand)-induced apoptosis. Conversely, a stable expression of the cDNA of hsp70 in the reverse orientation attenuated not only hsp70 but also signal transducers and activators of transcription 5 (STAT5) and Bcl-x(L) levels. This increased apoptosis induced by cytarabine, etoposide, or Apo-2L/TRAIL. Ectopic expression of hsp70 in HL-60 cells (HL-60/hsp70) inhibited Ara-C and etoposide-induced Bax conformation change and translocation to the mitochondria; attenuated the accumulation of cytochrome c, Smac, and Omi/HtrA2 in the cytosol; and inhibited the processing and activity of caspase-9 and caspase-3. Hsp70 was bound to death receptors 4 and 5 (DR4 and DR5) and inhibited Apo-2L/TRAIL-induced assembly and activity of the death-inducing signaling complex (DISC). HL-60/hsp70 cells exhibited increased levels and DNA binding activity of STAT5, which was associated with high levels of Pim-2 and Bcl-x(L) and resistance to apoptosis. Expression of the dominant negative (DN) STAT5 resensitized HL-60/hsp70 cells to cytarabine, etoposide, and Apo-2L/TRAIL-induced apoptosis. Collectively, these findings suggest that hsp70 inhibits apoptosis upstream and downstream of the mitochondria and is a promising therapeutic target for reversing drug-resistance in chronic myeloid leukemia-blast crisis and acute myeloid leukemia cells.

PubMed Disclaimer

Similar articles

• Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells.
  Wen J, Ramadevi N, Nguyen D, Perkins C, Worthington E, Bhalla K. Wen J, et al. Blood. 2000 Dec 1;96(12):3900-6. Blood. 2000. PMID: 11090076
• Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells.
  Guo F, Sigua C, Tao J, Bali P, George P, Li Y, Wittmann S, Moscinski L, Atadja P, Bhalla K. Guo F, et al. Cancer Res. 2004 Apr 1;64(7):2580-9. doi: 10.1158/0008-5472.can-03-2629. Cancer Res. 2004. PMID: 15059915
• Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin.
  Guo F, Rocha K, Bali P, Pranpat M, Fiskus W, Boyapalle S, Kumaraswamy S, Balasis M, Greedy B, Armitage ES, Lawrence N, Bhalla K. Guo F, et al. Cancer Res. 2005 Nov 15;65(22):10536-44. doi: 10.1158/0008-5472.CAN-05-1799. Cancer Res. 2005. PMID: 16288046
• Bcr-Abl and inhibition of apoptosis in chronic myelogenous leukemia cells.
  Fernandez-Luna JL. Fernandez-Luna JL. Apoptosis. 2000 Oct;5(4):315-8. doi: 10.1023/a:1009623222534. Apoptosis. 2000. PMID: 11227211 Review.
• Heat shock protein 70 (hsp70) as an emerging drug target.
  Evans CG, Chang L, Gestwicki JE. Evans CG, et al. J Med Chem. 2010 Jun 24;53(12):4585-602. doi: 10.1021/jm100054f. J Med Chem. 2010. PMID: 20334364 Free PMC article. Review. No abstract available.

Cited by

• TRAIL-induced apoptosis is enhanced by heat shock protein 70 expression.
  Clemons NJ, Anderson RL. Clemons NJ, et al. Cell Stress Chaperones. 2006 Winter;11(4):343-55. doi: 10.1379/csc-206.1. Cell Stress Chaperones. 2006. PMID: 17278883 Free PMC article.
• A Novel Inhibitor of STAT5 Signaling Overcomes Chemotherapy Resistance in Myeloid Leukemia Cells.
  Brachet-Botineau M, Deynoux M, Vallet N, Polomski M, Juen L, Hérault O, Mazurier F, Viaud-Massuard MC, Prié G, Gouilleux F. Brachet-Botineau M, et al. Cancers (Basel). 2019 Dec 17;11(12):2043. doi: 10.3390/cancers11122043. Cancers (Basel). 2019. PMID: 31861239 Free PMC article.
• Crossroad between the Heat Shock Protein and Inflammation Pathway in Acquiring Drug Resistance: A Possible Target for Future Cancer Therapeutics.
  Somu P, Basavegowda N, Gomez LA, Jayaprakash HV, Puneetha GK, Yadav AK, Paul S, Baek KH. Somu P, et al. Biomedicines. 2023 Sep 26;11(10):2639. doi: 10.3390/biomedicines11102639. Biomedicines. 2023. PMID: 37893013 Free PMC article. Review.
• Emerging Biosensing Methods to Monitor Lung Cancer Biomarkers in Biological Samples: A Comprehensive Review.
  Chinnappan R, Mir TA, Alsalameh S, Makhzoum T, Alzhrani A, Alnajjar K, Adeeb S, Al Eman N, Ahmed Z, Shakir I, Al-Kattan K, Yaqinuddin A. Chinnappan R, et al. Cancers (Basel). 2023 Jun 29;15(13):3414. doi: 10.3390/cancers15133414. Cancers (Basel). 2023. PMID: 37444523 Free PMC article. Review.
• A non-apoptotic function of caspase-3 in pharmacologically-induced differentiation of K562 cells.
  Sztiller-Sikorska M, Jakubowska J, Wozniak M, Stasiak M, Czyz M. Sztiller-Sikorska M, et al. Br J Pharmacol. 2009 Aug;157(8):1451-62. doi: 10.1111/j.1476-5381.2009.00333.x. Epub 2009 Jul 20. Br J Pharmacol. 2009. PMID: 19627286 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • GlyGen glycoinformatics resource

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal